Before starting any weight management strategydietary program, compounded GLP-1, or combined approachqualified healthcare providers should evaluate metabolic history, medication interactions, kidney and liver function, and gastrointestinal health
Medication is a tool, not a total solution
The glucagon component adds three distinct mechanisms: increased hepatic energy expenditure and thermogenesis (increasing resting metabolic rate by an estimated 100-200 kcal/day), enhanced hepatic fatty acid beta-oxidation (directly reducing liver fat), and lipolysis in both hepatic and adipose tissue
The most common side effects are mild and gastrointestinal, such as nausea or constipation, especially when starting
In clinical trials with participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight over 72 weeks [22]
Results are gradual and cumulative, not dramatic overnight changes